Hence, we decided to subdivide the patients (based on the microbiota composition and the IBD phenotype) into four groups: two eubiotic groups (UC1 and CD1) and two dysbiotic groups (UC2 and CD2). The gene discussed is CD2; the disease is inflammatory bowel disease.